7 assets in Psychiatric Disorder

Therapeutic assets addressing Psychiatric Disorder, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Rituximab Psychiatric Disorder	University Hospital, Bordeaux	P3	B (60)
Nicotine Psychiatric Disorder	Wake Forest University Health Sciences	P2	B (57)
Oxytocin Psychiatric Disorder	Shalvata Mental Health Center	P2	CCC (53)
Semaglutide Psychiatric Disorder	Ludwig-Maximilians - University of Munich	N/A	D (30)